← 返回专利悬崖列表
Norketotifen
Tier C · 观察 / 贸易Norketotifen
Emergo Therapeutics Inc
原研
-
首批上市
-
到期年(公开口径)
无销量数据
峰值销售
化学药
类型
靶点:HRH1
适应症(已批准):流感病毒感染、变应性结膜炎、过敏性鼻炎
各地区研发/上市状态
美国
临床二期
2019-04-01
欧盟
-
中国
-
日本
-
合成路线与中间体4 routes
原研路线 × 0优化路线(非专利)× 4工艺路线 × 0
路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。
优化Route 1步骤 1 · 总收率 14.74 g (Norketotifen)
Ketotifen34580-13-7Norketotifen34580-20-6API · Norketotifen
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| Ketotifen | 34580-13-7 | 4-(1-methylpiperidin-4-ylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one |
| Norketotifen | 34580-20-6 | 4-(piperidin-4-ylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one |
优化Route 2步骤 7 · 总收率 /
(I)471701-1-a4506-53-0(II)471701-1-a,(II)471701-1-b34580-10-4(III)471701-1-a43076-89-7(IV)471701-1-a59743-84-9(V)471701-1-a,(V)471701-1-b63463-36-5(VI)471701-1-a5570-77-4(VII)471701-1-a59743-88-3(VIII)471701-1-a,(VIII)471701-1-b34580-13-7(IXa)471701-1-a34580-19-3(IXb)471701-1-a—API · Norketotifen
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| (I)471701-1-a | 4506-53-0 | 6-Thiatricyclo[8.4.0.0(3,7)]tetradeca-1(14),3(7),4,8,10,12-hexaen-2-one |
| (II)471701-1-a,(II)471701-1-b | 34580-10-4 | 8,9-Dibromo-6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(10),3(7),4,11,13-pentaen-2-one |
| (III)471701-1-a | 43076-89-7 | 9-Bromo-10-methoxy-9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-one |
| (IV)471701-1-a | 59743-84-9在售 | 10-Methoxy-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-one |
| (V)471701-1-a,(V)471701-1-b | 63463-36-5 | 1-Methylpiperidn-4-ylmagnesium chloride |
| (VI)471701-1-a | 5570-77-4 | 4-Chloro-1-methylpiperidine |
| (VII)471701-1-a | 59743-88-3 | 10-Methoxy-4-(1-methylpiperidin-4-yl)-4H-benzo[4,5]cyclohepta[1,2-b]thiophene-4-ol |
| (VIII)471701-1-a,(VIII)471701-1-b | 34580-13-7 | 4-(1-Methyl-4-piperidinylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one |
| (IXa)471701-1-a | 34580-19-3 | 4-[8-Oxo-6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene]piperidine-1-carboxylic acid ethyl ester |
| (IXb)471701-1-a | - | 1-Chloroethyl 4-(10-oxo-9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)piperidine-1-carboxylate |
优化Route 3步骤 6 · 总收率 /
(II)471701-1-a,(II)471701-1-b34580-10-4(V)471701-1-a,(V)471701-1-b63463-36-5(VIII)471701-1-a,(VIII)471701-1-b34580-13-7(X)471701-1-b1622-55-5(XI)471701-1-b34580-11-5(XII)471701-1-b59776-37-3(XIII)471701-1-b34580-12-6(XIV)471701-1-b110-89-4(XV)471701-1-b59743-85-0(XVI)471701-1-b59743-86-1(XVII)471701-1-b34580-09-1API · Norketotifen
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| (II)471701-1-a,(II)471701-1-b | 34580-10-4 | 8,9-Dibromo-6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(10),3(7),4,11,13-pentaen-2-one |
| (V)471701-1-a,(V)471701-1-b | 63463-36-5 | 1-Methylpiperidn-4-ylmagnesium chloride |
| (VIII)471701-1-a,(VIII)471701-1-b | 34580-13-7 | 4-(1-Methyl-4-piperidinylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one |
| (X)471701-1-b | 1622-55-5在售 | 6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(10),3(7),4,11,13-pentaen-2-one |
| (XI)471701-1-b | 34580-11-5 | 8-bromo-6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(10),3(7),4,8,11,13-hexaen-2-one |
| (XII)471701-1-b | 59776-37-3 | 8-bromo-2-(1-methylpiperidin-4-yl)-6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(10),3(7),4,8,11,13-hexaen-2-ol |
| (XIII)471701-1-b | 34580-12-6 | 4-{8-bromo-6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(10),3(7),4,8,11,13-hexaen-2-ylidene}-1-methylpiperidine |
| (XIV)471701-1-b | 110-89-4 | Azacyclohexane |
| (XV)471701-1-b | 59743-85-0 | 1-Methyl-4-[9-(piperidin-1-yl)-6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(14),3(7),4,8,10,12-hexaen-2-ylidene]piperidine |
| (XVI)471701-1-b | 59743-86-1 | 1-methyl-4-[8-(piperidin-1-yl)-6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(10),3(7),4,8,11,13-hexaen-2-ylidene]piperidine |
| (XVII)471701-1-b | 34580-09-1 | 2-(1-Methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(14),3(7),4,10,12-pentaen-9-one |
优化Route 4步骤 2 · 总收率 /
(I)471701-2-a34580-13-7(IIa)471701-2-a108-24-7(IIb)471701-2-a1609-47-8(IIc)471701-2-a123-62-6(IId)471701-2-a93-97-0(IIe)471701-2-a31139-36-3(IIf)471701-2-a106-31-0(IIIa)471701-2-a117540-07-5(IIIb)471701-2-a34580-19-3(IIIc)471701-2-a2489527-25-3(IIId)471701-2-a2489527-27-5(IIIe)471701-2-a2489527-28-6(IIIf)471701-2-a2489527-26-4API · Norketotifen
| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| (I)471701-2-a | 34580-13-7 | 4-(1-Methyl-4-piperidinylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one |
| (IIa)471701-2-a | 108-24-7 | Acetic acid acetic anhydride |
| (IIb)471701-2-a | 1609-47-8 | Dicarbonic acid diethyl diester |
| (IIc)471701-2-a | 123-62-6在售 | Methylacetic anhydride |
| (IId)471701-2-a | 93-97-0 | Benzoic acid anhydride |
| (IIe)471701-2-a | 31139-36-3 | Dibenzyl dicarbonate |
| (IIf)471701-2-a | 106-31-0 | Butanoic acid 1-oxobutyl ester |
| (IIIa)471701-2-a | 117540-07-5 | 4-(1-Acetylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one |
| (IIIb)471701-2-a | 34580-19-3 | 4-[8-Oxo-6-thiatricyclo[8.4.0.0(3,7)]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene]piperidine-1-carboxylic acid ethyl ester |
| (IIIc)471701-2-a | 2489527-25-3 | 4-(1-Propanoylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one |
| (IIId)471701-2-a | 2489527-27-5 | 4-(1-Benzoylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one |
| (IIIe)471701-2-a | 2489527-28-6 | Benzyl 4-(10-oxo-9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)piperidine-1-carboxylate |
| (IIIf)471701-2-a | 2489527-26-4 | 4-(1-Butanoylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one |
常见问题(FAQ)
Norketotifen的适应症有哪些?
已批准的适应症包括:流感病毒感染、变应性结膜炎、过敏性鼻炎。
Norketotifen的专利什么时候到期?
Norketotifen的专利到期年暂无公开口径,本页会在数据管道核实后更新。
Norketotifen有几条合成路线?
本站收录 4 条合成路线,最短路线 1 步、总收率 14.74 g (Norketotifen)。每条路线的中间体均带登记编号与 CAS 号。
Norketotifen的关键中间体在哪里可以采购?
Norketotifen的多条路线中间体已挂接 CAS 档案,其中 3 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。
如何获取Norketotifen中间体的报价?
在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。
数据来源:多源数据交叉核实(仅结构化字段) · 2026-10-08